Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison

Clicks: 651
ID: 111746
2003
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #2 of 77 articles by views in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Piperacillin-tazobactam monotherapy is significantly more effective and cost-efficient than ceftriaxone plus gentamicin as first-line therapy in febrile neutropenic patients with hematological malignancies.
Reference Key
m2003supportivepiperacillin-tazobactam Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Gorschlüter M;Hahn C;Fixson A;Mey U;Ziske C;Molitor E;Horré R;Sauerbruch T;Marklein G;Schmidt-Wolf IG;Glasmacher A;;
Journal Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Year 2003
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/12690546
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't adult female male adolescent aged middle aged 80 and over Clinical Trial Randomized Controlled Trial drug therapy combination fever / drug therapy* gentamicins / administration & dosage anti-bacterial agents / pharmacology* neutropenia / drug therapy* anti-bacterial agents / administration & dosage fever / etiology neutropenia / etiology penicillins / pharmacology* enzyme inhibitors / administration & dosage pmid:12690546 doi:10.1007/s00520-003-0463-7 m gorschlüter c hahn a glasmacher anti-bacterial agents / economics ceftriaxone / administration & dosage ceftriaxone / economics ceftriaxone / pharmacology* cost-benefit analysis enzyme inhibitors / economics enzyme inhibitors / pharmacology* gentamicins / economics gentamicins / pharmacology* hematologic neoplasms / complications penicillanic acid / administration & dosage penicillanic acid / analogs & derivatives* penicillanic acid / economics penicillanic acid / pharmacology* penicillins / administration & dosage penicillins / economics piperacillin / administration & dosage piperacillin / economics piperacillin / pharmacology* tazobactam

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.